Central role of cyclooxygenase in the response of canine peripheral airways to antigen.
We studied the effects of antigen aerosol challenge on the airways of the canine peripheral lung and examined the roles of cyclooxygenase products, histamine, and cholinergic activity in the responses. One-minute deliveries of 1:10,000 or 1:100,000 concentrations of Ascaris suum antigen aerosol through a wedged bronchoscope resulted in mean maximal increases in collateral system resistance (Rcs) of 415 and 177%, respectively, after 4-8 min. Repeated antigen challenge (1:100,000) resulted in significantly decreased responsiveness to antigen after the initial exposure (P less than 0.005). Bronchoalveolar lavage fluid obtained from the isolated, challenged segment had a significant increase in mean (+/- SE) prostaglandin D2 (PGD2) concentration vs. control (222.0 +/- 65.3 vs. 72.7 +/- 19.5 pg/ml; P less than 0.05); histamine concentrations were variable and not significantly different (4.1 +/- 2.6 vs. 1.2 +/- 0.2 ng/ml; P greater than 0.05). In nine experiments, cyclooxygenase inhibition significantly attenuated the antigen-induced increase in Rcs by 53.4% (P less than 0.001), and the concentration of PGD2 in lavage fluid was reduced by 96.0% (P less than 0.01). Blockade of histamine H1-receptors (n = 8) or cholinergic receptors (n = 7) did not significantly affect the airway response (P greater than 0.05). These data indicate that the canine peripheral lung responds in a dose-dependent manner to antigen aerosol challenge and exhibits characteristics of antigen tachyphylaxis. Results also suggest that cyclooxygenase products play a central role in the acute bronchoconstrictive response of the lung periphery.
D000336:Aerosols; D000818:Animals; D000941:Antigens / Q000008:administration & dosage*; D000947:Antigens, Helminth / Q000276:immunology; D001200:Ascaris / Q000276:immunology; D002744:Chlorpheniramine / Q000494:pharmacology; D004285:Dogs; D006636:Histamine Release; D007213:Indomethacin / Q000494:pharmacology; D008168:Lung / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D008297:Male; D010047:Ovalbumin / Q000008:administration & dosage; D015230:Prostaglandin D2; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D011457:Prostaglandins D / Q000032:analysis; D007507:Therapeutic Irrigation
D000336:Aerosols; D000941:Antigens; D000947:Antigens, Helminth; D011457:Prostaglandins D; D002744:Chlorpheniramine; D010047:Ovalbumin; D011451:Prostaglandin-Endoperoxide Synthases; D015230:Prostaglandin D2; D007213:Indomethacin